Hutton Chapman

Conference Cancer Epidemiology, Biomarkers & Prevention · December 1, 2025 AbstractPurpose:Despite their increasing use in clinical practice and research in high resource settings, the use of patient re ... Full text Cite

Implementation Methodology for the Introduction of High-Dose Methotrexate in Low-Resource Settings for the Treatment of Burkitt Lymphoma

Conference PEDIATRIC BLOOD & CANCER · December 2025 Link to item Cite

Development of an Evidence-Based Clinical Tool for Childhood Cancer Survivorship Care in Tanzania

Conference Blood · November 2, 2023 CONCLUSIONSThree in every four childhood cancer survivors experience late effects from treatment. As childhood cancer outcomes improve globally, it is important for providers to screen for these potential la ... Full text Cite

Analysis of Nutrition Status and Outcomes for Pediatric Patients with Burkitt Lymphoma Treated in Mwanza, Tanzania

Conference Blood · November 2, 2023 Introduction: Despite decades of improvement in outcomes for pediatric cancers in High-Income Countries (HICs), outcomes remain incredibly disparate as compared to those achieved in Low- and Middle-Income Countries (LMI ... Full text Cite

RETROSPECTIVE ANALYSIS OF PEDIATRIC PATIENTS WITH BURKITT LYMPHOMA TREATED IN MWANZA, TANZANIA; CHALLENGES AND OPPORTUNITY

Conference PEDIATRIC BLOOD & CANCER · November 2023 Link to item Cite

UNDERSTANDING THE CAUSES OF DEATH FOR CHILDREN DIAGNOSED WITH BURKITT LYMPHOMA AT REGIONAL CANCER REFERRAL HOSPITAL IN TANZANIA

Conference PEDIATRIC BLOOD & CANCER · November 2023 Link to item Cite

Abstract 33: Epidemiology, Diagnosis, and Outcomes of Pediatric Burkitt Lymphoma Patients Treated at Bugando Medical Centre in Mwanza, Tanzania

Conference Cancer Epidemiology, Biomarkers & Prevention · June 1, 2023 AbstractPurpose: Despite the significant improvement in outcomes over the last few decades for the treatment of pediatric Burkitt lymphoma, outcomes in sub-Saharan Africa remain poor, with an approximately 5 ... Full text Cite